Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Pipeline Review, H2 2016 - Research and Markets

Research and Markets
Posted on: 18 Oct 16

Research and Markets has announced the addition of the "Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Melanocyte Stimulating Hormone Receptor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Melanocyte Stimulating Hormone Receptor and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Clinuvel Pharmaceuticals Limited
  • Mallinckrodt Plc
  • Palatin Technologies, Inc.
  • Retrophin Inc.
  • SolaranRx, Inc

Key Topics Covered:

  • Introduction
  • Melanocyte Stimulating Hormone Receptor Overview
  • Therapeutics Development
  • Pipeline Products for Melanocyte Stimulating Hormone Receptor - Overview
  • Pipeline Products for Melanocyte Stimulating Hormone Receptor - Comparative Analysis
  • Melanocyte Stimulating Hormone Receptor - Therapeutics under Development by Companies
  • Melanocyte Stimulating Hormone Receptor - Therapeutics under Investigation by Universities/Institutes
  • Melanocyte Stimulating Hormone Receptor - Pipeline Products Glance
  • Late Stage Products
  • Clinical Stage Products
  • Early Stage Products
  • Melanocyte Stimulating Hormone Receptor - Products under Development by Companies
  • Melanocyte Stimulating Hormone Receptor - Products under Investigation by Universities/Institutes
  • Melanocyte Stimulating Hormone Receptor - Companies Involved in Therapeutics Development

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/qgwjq4/melanocyte

View source version on businesswire.com: http://www.businesswire.com/news/home/20161018006329/en/

Business Wire
www.businesswire.com

Last updated on: 18/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.